Viewing Study NCT00000217



Ignite Creation Date: 2024-05-05 @ 10:00 AM
Last Modification Date: 2024-10-26 @ 9:01 AM
Study NCT ID: NCT00000217
Status: COMPLETED
Last Update Posted: 2015-04-16
First Post: 1999-09-20

Brief Title: Pharmacotherapy and Intensive Treatment of Drug Abuse - 1
Sponsor: University of Kansas
Organization: University of Kansas Medical Center

Study Overview

Official Title: Pharmacotherapy and Intensive Treatment of Drug Abuse
Status: COMPLETED
Status Verified Date: 2015-04
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The purpose of this study is to evaluate desipramine and carbamazepine in reducing cocaine craving increase outpatient treatment capacity and evaluate their incidence of psychiatric disorders
Detailed Description: None

Study Oversight

Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?:
Secondary IDs
Secondary ID Type Domain Link
R18-06954-1 US NIH GrantContract None httpsreporternihgovquickSearchR18DA006954
R18DA006954 NIH None None